Proteasomal Degradation of N-Acetyltransferase 1 Is Prevented by Acetylation of the Active Site Cysteine

This publication has 23 references indexed in Scilit:

• Redox Regulation of the Human Xenobiotic Metabolizing Enzyme Arylamine N-Acetyltransferase 1 (NAT1)
  Journal of Biological Chemistry, 2003
• Reversible inhibition of the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 by S-nitrosothiols
  Biochemical and Biophysical Research Communications, 2003
• Pharmacogenetics of the arylamine N-acetyltransferases
  The Pharmacogenomics Journal, 2002
• Functional characterization of nucleotide polymorphisms in the coding region of N-acetyltransferase 1
  Pharmacogenetics, 2001
• Substrate-Dependent Regulation of Human ArylamineN-Acetyltransferase-1 in Cultured Cells
  Molecular Pharmacology, 2000
• Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe
  Pharmacogenetics, 1998
• Functional polymorphism of the human arylamine JV-acetyltransferase type 1 gene caused by C190T and G560A mutations
  Pharmacogenetics, 1998
• Purification of recombinant human N-Acetyltransferase type 1 (NAT1) expressed in E. Coli and characterization of its potential role in folate metabolism
  Biochemical Pharmacology, 1995
• Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells
  Biochemical Journal, 1995
• Isotope exchange studies on rabbit liver N-acetyltransferase
  Biochimica et Biophysica Acta (BBA) - Enzymology, 1971